Lnhc Drug Patent Portfolio
Lnhc owns 2 orange book drugs protected by 17 US patents Given below is the list of Lnhc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10322081 | Topical antiviral compositions and methods of using the same | 10 Jul, 2035 | Active |
| US10736839 | Topical antiviral compositions, delivery systems, and methods of using the same | 10 Jul, 2035 | Active |
| US11040006 | Topical antiviral compositions, delivery systems, and methods of using the same | 10 Jul, 2035 | Active |
| US11723858 | Topical antiviral compositions, delivery systems, and methods of using the same | 10 Jul, 2035 | Active |
| US10258564 | Topical compositions and methods of using the same | 22 Nov, 2034 | Active |
| US11285098 | Topical compositions and methods of using the same | 28 Feb, 2034 | Active |
| US9855211 | Topical compositions and methods of using the same | 27 Feb, 2034 | Active |
| US10265334 | Anhydrous compositions | 03 Jul, 2032 | Active |
| US9289442 | Topical compositions | 03 Jul, 2032 | Active |
| US9180200 | Pharmaceutical topical compositions | 29 Jan, 2032 | Active |
| US9526738 | Topical gels and methods of using the same | 03 Sep, 2031 | Active |
| US10376538 | Topical gels and methods of using the same | 20 Aug, 2030 | Active |
| US9737561 | Topical gels and methods of using the same | 20 Aug, 2030 | Active |
| US9399014 | Pharmaceutical topical compositions | 15 Dec, 2029 | Active |
| US8282967 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | 30 May, 2026 | Active |
| US8956658 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | 30 May, 2026 | Active |
| US6335447 | Quinolonecarboxylic acid derivatives or salts thereof | 09 Nov, 2023 | Expired |
Latest Legal Activities on Lnhc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lnhc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 27 Jun, 2024 | US9526738 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 22 Mar, 2024 | US8282967 |
|
Email Notification
Critical
| 05 Mar, 2024 | US9855211 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 05 Mar, 2024 | US9855211 |
| Initial letter Re: PTE Application to regulating agency | 04 Mar, 2024 | US9855211 |
| Patent Term Extension Application under 35 USC 156 Filed | 01 Mar, 2024 | US9855211 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 12 Feb, 2024 | US10736839 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 26 Jan, 2024 | US9399014 |
|
Electronic Review
Critical
| 15 Aug, 2023 | US11723858 |
| Recordation of Patent eGrant | 15 Aug, 2023 | US11723858 |
|
Email Notification
Critical
| 15 Aug, 2023 | US11723858 |
| Mail Patent eGrant Notification | 15 Aug, 2023 | US11723858 |
| Patent eGrant Notification | 15 Aug, 2023 | US11723858 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Aug, 2023 | US11723858 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Aug, 2023 | US11723858 |
Lnhc's Family Patents
Lnhc drugs have patent protection in a total of 23 countries. It's US patent count contributes only to 13.5% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Lnhc Drug List
Given below is the complete list of Lnhc's drugs and the patents protecting them.
1. Xepi
Xepi is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9180200 | Pharmaceutical topical compositions |
29 Jan, 2032
(5 years from now)
| Active |
| US9399014 | Pharmaceutical topical compositions |
15 Dec, 2029
(3 years from now)
| Active |
| US6335447 | Quinolonecarboxylic acid derivatives or salts thereof |
09 Nov, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xepi's drug page
2. Zelsuvmi
Zelsuvmi is protected by 14 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10322081 | Topical antiviral compositions and methods of using the same |
10 Jul, 2035
(9 years from now)
| Active |
| US10736839 | Topical antiviral compositions, delivery systems, and methods of using the same |
10 Jul, 2035
(9 years from now)
| Active |
| US11040006 | Topical antiviral compositions, delivery systems, and methods of using the same |
10 Jul, 2035
(9 years from now)
| Active |
| US11723858 | Topical antiviral compositions, delivery systems, and methods of using the same |
10 Jul, 2035
(9 years from now)
| Active |
| US10258564 | Topical compositions and methods of using the same |
22 Nov, 2034
(8 years from now)
| Active |
| US11285098 | Topical compositions and methods of using the same |
28 Feb, 2034
(8 years from now)
| Active |
| US9855211 | Topical compositions and methods of using the same |
27 Feb, 2034
(8 years from now)
| Active |
| US10265334 | Anhydrous compositions |
03 Jul, 2032
(6 years from now)
| Active |
| US9289442 | Topical compositions |
03 Jul, 2032
(6 years from now)
| Active |
| US9526738 | Topical gels and methods of using the same |
03 Sep, 2031
(5 years from now)
| Active |
| US10376538 | Topical gels and methods of using the same |
20 Aug, 2030
(4 years from now)
| Active |
| US9737561 | Topical gels and methods of using the same |
20 Aug, 2030
(4 years from now)
| Active |
| US8282967 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
30 May, 2026
(3 months from now)
| Active |
| US8956658 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
30 May, 2026
(3 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zelsuvmi's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List